John Crowley: A Legacy of Biotechnology Innovation and Rare Disease Advocacy
John Crowley is a distinguished leader in the global biotechnology sector, currently serving as the President and CEO of the Biotechnology Innovation Organization (BIO), the world's largest advocacy group for the industry. His career is defined by a unique intersection of professional expertise in law and business and a deeply personal mission to combat rare genetic disorders.
Crowley's journey from a corporate executive to a champion for patients was catalyzed by a family crisis that transformed his approach to medicine and entrepreneurship. His efforts have not only saved his own children but have paved the way for treatments benefiting thousands of patients worldwide.
ไม่มีภาพประกอบ
Key Facts
- Current Role: President and CEO of the Biotechnology Innovation Organization (BIO), appointed in 2023.
- Major Achievements: Co-founded Novazyme Pharmaceuticals and served as CEO of Amicus Therapeutics.
- Personal Mission: Led the quest to find a treatment for Pompe disease after his children, Megan and Patrick, were diagnosed.
- Education: Holds degrees from the United States Naval Academy, Georgetown University (BS), Notre Dame Law School (JD), and Harvard Business School (MBA).
- Public Impact: Inspiration for the 2010 film Extraordinary Measures and author of the memoir Chasing Miracles.
Early Life and Academic Foundation
Born on April 7, 1967, in Englewood, New Jersey, John Crowley was raised in a family with Irish and Italian Catholic roots. His early life was marked by tragedy when his father, an Englewood police officer, died in the line of duty when John was eight years old.
Crowley pursued a rigorous academic path, beginning with the United States Naval Academy. He later earned a Bachelor of Science in Foreign Service from Georgetown University, followed by a Juris Doctor (JD) from Notre Dame Law School in 1992. After starting his career as a litigation associate in healthcare law, he furthered his business acumen by earning an MBA from Harvard Business School in 1997.
The Fight Against Pompe Disease
In 1998, Crowley's life changed when his children, Megan and Patrick, were diagnosed with glycogen storage disease type II, commonly known as Pompe disease. This severe neuromuscular disorder causes progressive muscle weakness and heart failure.
Determined to find a cure, Crowley immersed himself in medical research while working at Bristol-Myers Squibb. He discovered that researchers across Europe and the U.S. were working in isolation. To bridge this gap, he partnered with William Canfield in 2000 to launch Novazyme Pharmaceuticals in Oklahoma City.
Novazyme was acquired by Genzyme Corporation in 2001. Under Genzyme's R&D efforts, an enzyme replacement therapy (ERT)—a treatment that replaces a missing or defective enzyme in the body—called Lumizyme was developed. In 2003, Megan and Patrick received this therapy, which successfully reduced the size of their hearts and improved their muscle strength.
ไม่มีภาพประกอบ
Corporate Leadership and Biotech Innovation
Following his success with Genzyme, Crowley founded Orexigen Therapeutics in 2003. He later joined Amicus Therapeutics, serving as President and CEO starting in 2005. At Amicus, he focused on developing treatments for rare genetic disorders, including Galafold (migalastat) for Fabry disease, which received European approval in 2016, and treatments for epidermolysis bullosa (EB).
In 2023, Crowley transitioned to the helm of the Biotechnology Innovation Organization (BIO), where he now leads global advocacy for the biotech industry.
| Organization | Role | Key Contribution/Focus |
|---|---|---|
| Novazyme Pharmaceuticals | Co-founder & CEO | Research for Pompe disease treatment |
| Genzyme Corporation | Senior Vice President | Led global Pompe program and Lumizyme development |
| Orexigen Therapeutics | Founding President & CEO | Biotechnology entrepreneurship |
| Amicus Therapeutics | President & CEO | Treatments for Fabry disease and EB |
| BIO | President & CEO | Global biotechnology advocacy |
Public Service, Politics, and Philanthropy
Beyond the boardroom, Crowley has been a dedicated public servant. He served as an intelligence officer in the United States Navy Reserve, including active duty at the Center for Naval Intelligence in 2007.
In the political sphere, Crowley has been a powerful voice for patient safety and rare disease research. He was instrumental in forming the bi-partisan Congressional Caucus on Rare Diseases in 2010 and has testified before the Senate Committee on Health, Education, Labor and Pensions.
His philanthropic work is equally extensive. He served as the national chairman of the Make-A-Wish Foundation of America starting in 2014, continuing his commitment to improving the lives of children with critical illnesses.
Cultural Impact: Books and Film
The story of the Crowley family's struggle and triumph has reached a global audience through various media. Journalist Geeta Anand detailed their journey in the 2006 book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children.
This narrative inspired the 2010 film Extraordinary Measures, starring Brendan Fraser as John Crowley and Harrison Ford as a composite character based on the doctors who helped the family. Additionally, Crowley co-authored the memoir Chasing Miracles: The Crowley Family Journey of Strength, Hope and Joy to share his personal perspective on resilience.
Frequently Asked Questions
What is Pompe disease?
Pompe disease, or glycogen storage disease type II, is a severe neuromuscular disorder that causes muscle weakness and can lead to heart failure if left untreated.
How did John Crowley contribute to the treatment of Pompe disease?
Crowley co-founded Novazyme Pharmaceuticals to accelerate research, which led to the development of Lumizyme, an enzyme replacement therapy that saved his children and other patients.
What is the Biotechnology Innovation Organization (BIO)?
BIO is the world's largest biotechnology advocacy organization, focused on promoting the industry and advancing the development of innovative medicines.
Which movie is based on John Crowley's life?
The 2010 film Extraordinary Measures, starring Brendan Fraser and Harrison Ford, is inspired by the Crowley family's quest to find a cure for their children.
What other rare diseases has Crowley worked on?
During his time at Amicus Therapeutics, Crowley oversaw the development of treatments for Fabry disease (Galafold) and epidermolysis bullosa (EB).